In addition, key stemness markers, including NANOG, OCT4 and SOX2, were markedly upregulated in DUSP9‐overexpressing tumours, whereas their expression was significantly reduced in DUSP9‐knockdown tumours, further supporting the role of DUSP9 in promoting stemness. Here, DUSP9 is linked to neoplasm.